NJ Court Keeps Some Claims Alive In Cordis Stent Case

Law360, New York (August 9, 2012, 5:04 PM EDT) -- The New Jersey Supreme Court ruled Thursday that while federal law preempts most state and common law claims in litigation over an allegedly defective coronary stent made by Cordis Corp., elements of failure to warn and breach of express warranty claims can stand for now.

Ruling on an appeal involving 48 consolidated complaints, the court backed limited exceptions to preemption by the Medical Device Amendments of 1976 to the Food, Drug and Cosmetic Act to the extent that those claims avoided territory governed by the U.S....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.